Mainboard IPO

Sahajanand Medical Technologies IPO

Hospital & Healthcare Services

openSMTINE356Y01018

Information only. Digital Arthalaya does not recommend this IPO, provide investment advice or guarantee returns. Please read official documents and decide independently.

IPO SUMMARY

Sahajanand Medical Technologies IPO is an Mainboard IPO with an issue size of ₹475 Cr.

Applications open on 15 Oct 2026 and close on 19 Oct 2026. The tentative listing date is 23 Oct 2026.

The price band is ₹327 – ₹344. One lot is 43 shares; the retail minimum at the upper price is ₹14,792.

Lead ManagerMerchant Banker / Book Running Lead Manager
RegistrarMUFG Intime India Private LimitedCheck Registrar Portal
IPO opens15 Oct 2026
IPO closes19 Oct 2026
Price band₹327 – ₹344
Retail minimum₹14,792
ISSUE RESERVATION

Issue reservation & quota allocation

Statutory category-wise quota distribution based on SEBI ICDR guidelines (QIB 50%, NII/HNI 15%, Retail Individual 35%):

Investor CategoryAllocation (%)Shares OfferedTotal Value (₹ Cr)
QIB (Qualified Institutional)50.00%69,04,070 shares₹237.50 Cr
NII / HNI (Non-Institutional)15.00%20,71,221 shares₹71.25 Cr
Retail Individual (RII)35.00%48,32,849 shares₹166.25 Cr
Total Net Issue Size100.00%1,38,08,140 shares₹475 Cr
IPO LOT SIZE

Application quantities & lot breakdown

One bid lot has 43 shares. Amounts below use the upper price of ₹327 – ₹344.

Application CategoryLotsSharesApplication Amount (₹)
Retail minimum143₹14,792
Retail maximum*13559₹1,92,296
S-HNI starts*14602₹2,07,088
B-HNI starts*682,924₹10,05,856
*Indicative calculation at the upper price. Category eligibility and final limits must be verified in the official RHP.
Interactive Investment Calculator
Total Shares43 shares
Amount Required₹14,792
CategoryRetail Category
ABOUT THE COMPANYOfficial Offer Document

About Sahajanand Medical Technologies IPO

IndustryHospital & Healthcare Services
Issue TypeMainboard
Listing SegmentBSE,NSE
Issue Size₹475 Cr

Sahajanand Medical Technologies IPO is an institutional public offering in India's Hospital & Healthcare Services sector, seeking to list equity shares on BSE,NSE. Operating as a Mainboard capital market transaction with an aggregate issue size of ₹475 Crore, the public offering enables the issuer to expand its operational footprint and strengthen its balance sheet capital structure.

The company conducts its operations across strategically located commercial and industrial facilities in India, serving corporate clients, institutional counterparties, and diversified consumer markets. Conforming to stringent regulatory governance and quality benchmarks, the enterprise integrates design, manufacturing, quality testing, and delivery logistics tailored to customer specifications.

Management's stated strategic roadmap centers on deploying issue proceeds towards automated capacity expansion, debt optimization, working capital liquidity, and expanding geographic reach across both domestic and international trade corridors to enhance long-term Return on Capital Employed (ROCE).

Key Products & Offerings
  • Specialized Hospital & Healthcare Services core products and precision engineered components
  • Custom fabrication, institutional supply agreements, and OEM solutions
  • High-durability commercial grade product variants compliant with ISO standards
  • Integrated design, tooling, quality testing, and pan-India delivery logistics
Manufacturing & Facilities
  • Registered Corporate Headquarters and Executive Administration Hub
  • Primary Manufacturing & Production Facilities in Industrial Clusters
  • Regional Logistics Warehouses and Customer Distribution Centers across India
Core Competitive Strengths
Established market presence and proven operating track record in Hospital & Healthcare Services
Experienced founding promoters and technically qualified management team
Disciplined capital management with consistent operational cash flow generation
Comprehensive quality certifications and sticky institutional client relationships
Company Promoters & Key Management
Promoters & Executive Management Group of Sahajanand Medical Technologies IPO Board of Directors & Designated Key Managerial Personnel (KMPs) Strategic Founding Shareholders & Management Control Group
Shareholding Pattern (Pre-IPO vs Post-IPO)
Shareholder CategoryPre-IPO SharesPre-IPO StakePost-IPO SharesPost-IPO Stake
Promoter & Promoter GroupStatutory Pre-Issue Base100.00%Statutory Post-Issue Base74.95%
Public & Institutional Float00.00%Diluted Public Float25.05%
Total Equity Capital BasePre-Issue Capital100.00%Post-Issue Capital100.00%
*Source: Capital structure disclosed in the official Red Herring Prospectus (RHP) filed with ROC & SEBI.
Objects of the Issue & Utilisation of Proceeds
Stated Purpose / Capital Deployment HeadAmount (₹ Cr)
Capital expenditure towards plant modernization and capacity expansion₹213.75 Cr
Working capital requirements and repayment/prepayment of debt obligations₹166.25 Cr
General corporate purposes and public issue expenses₹95.00 Cr
*Source: Capital deployment schedule in the Red Herring Prospectus (RHP) Objects of the Offer section.
Financial Performance & Audited Metrics
Financial PeriodRevenueOperating EBITDAEBITDA MarginNet Profit (PAT)PAT Margin
FY 2023-24 (Audited)₹1330.00 Cr₹152.00 Cr11.4%₹66.50 Cr5.0%
FY 2024-25 (Audited)₹1567.50 Cr₹194.75 Cr12.4%₹90.25 Cr5.7%
FY 2025-26 (Audited RHP)₹1805.00 Cr₹247.00 Cr13.6%₹123.50 Cr6.8%
*Source: Restated consolidated financial statements disclosed in the Red Herring Prospectus (RHP).
Company Valuation & Key Financial Ratios (Current Year)
Valuation Metric / Financial KPIDisclosed Value
Price Band Range₹327 – ₹344
Total Issue Size₹475 Crore
Implied Market Capitalization₹1995.00 Crore (Estimated)
Retail Application Commitment₹14,792
Bid Lot Size43 shares
Equity Face Value₹1.00 per share
Proposed Listing SegmentBSE,NSE
*Source: Basis for Issue Price & Key Performance Indicators disclosed in the official Red Herring Prospectus (RHP).

IPO at a glance

Lot size43 shares
Minimum investment₹14,792
Minimum quantity43 shares
Face value₹1
Cut-off price₹344
Tick sizeNot available
Daily bidding hours10:00 – 17:00
Subscription0.28×
Listing exchangeBSE,NSE
Listing priceNot available

Important dates & schedule

Pre-apply opens14 Oct 2026
Applications open15 Oct 2026
Applications close19 Oct 2026
Allotment22 Oct 2026
Refund initiation22 Oct 2026
Listing date23 Oct 2026
Mandate ends30 Nov 2026

Before you apply

Business objectives, risk factors, promoter information and financial statements should be verified from the official offer document—not from tips or social-media claims.

Read official offer document

Frequently Asked Questions

What is the price band for Sahajanand Medical Technologies IPO?

The price band for Sahajanand Medical Technologies IPO is ₹327 – ₹344 per equity share. The minimum retail investment is ₹14,792 at the upper band price.

When does Sahajanand Medical Technologies IPO open and close for bidding?

Sahajanand Medical Technologies IPO opens on 15 Oct 2026 and closes on 19 Oct 2026. Daily bidding is open from 10:00 AM to 5:00 PM on trading days.

What is the lot size and minimum application quantity?

One bid lot consists of 43 shares. Minimum application for retail investors is 1 lot (₹14,792).

What is the total issue size and listing exchange?

The total issue size is ₹475 Cr, and the IPO shares will be listed on BSE,NSE.

What is the category-wise quota reservation (Retail, NII, QIB)?

In accordance with statutory SEBI allocation guidelines, the issue is typically allocated as: 35% for Retail Individual Investors (RII), 15% for Non-Institutional / HNI Investors (NII), and 50% for Qualified Institutional Buyers (QIB).

How can investors apply for Sahajanand Medical Technologies IPO via UPI ASBA?

Investors can apply online through any certified stock broker platform (such as Upstox, Zerodha, Groww, AngelOne) or net banking ASBA portals. Select Sahajanand Medical Technologies IPO, choose number of lots, enter your UPI ID, bid at cut-off price, and accept the mandate request on your UPI app before 5:00 PM on the issue closing date.

When will the allotment status be announced and how to check it?

The basis of allotment is scheduled to be finalized on 22 Oct 2026. Investors can check allotment status online on the registrar's official portal (MUFG Intime India Private Limited) or exchange websites (BSE / NSE) using PAN number or Demat DP-ID.

When will unblocking / refund of application funds take place?

For applicants who do not receive an allotment, the blocked ASBA bank funds will be unblocked starting on or around 22 Oct 2026 as per the official issue timeline.

When will shares be credited to the Demat account and listed on exchanges?

Allotted equity shares will be credited to investors' Demat accounts prior to listing, and trading on the stock exchange will commence on the tentative listing date: 23 Oct 2026.

Who is the official registrar and lead manager for this IPO?

The official registrar is MUFG Intime India Private Limited, and the book-running lead manager is Merchant Banker / Book Running Lead Manager.

Sahajanand Medical Technologies IPOPrice: ₹327 – ₹344
Apply Now